However, given that, on certain occasions, biopsies may not contain a sufficient percentage of tumor cells for correct analysis of the MMR status (as well as other genes of special interest), a significant number of patients may find themselves limited in their therapeutic options (16). The gene discussed is MRC1; the disease is neoplasm.